πŸ‡ΊπŸ‡Έ FDA
Patent

US 9493467

PI3 kinase antagonists

granted A61PA61P11/00A61P11/06

Quick answer

US patent 9493467 (PI3 kinase antagonists) held by The Regents of the University of California expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P11/00, A61P11/06, A61P19/02, A61P19/08